Dr Rouchelle Srinanjan-Rothwell, NIHR clinical lecturer at the University of Cambridge, talks about her recently published IVORY trial, in which the Cambridge team investigated anti-inflammatory therapy using repurposed IL-2 drug to treat acute coronary syndromes

You can find the study here: Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial | Nature Medicine

In this episode, we also hear from Mark Andrews, recently treated at CUH for a heart attack, and who took part in the trial.

Let us know what you would like to hear from next by commenting!